Advisors Management Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-116,330
| Closed | -$3.27M | – | 162 |
|
|
2026
Q1 | $3.27M | Sell |
116,330
-32,065
| -22% | -$854K | 0.6% | 46 |
|
|
2025
Q4 | $3.69M | Sell |
148,395
-39,525
| -21% | -$997K | 0.67% | 43 |
|
|
2025
Q3 | $4.79M | Sell |
187,920
-1,753
| -0.9% | -$43.3K | 0.84% | 38 |
|
|
2025
Q2 | $4.6M | Sell |
189,673
-1,271
| -0.7% | -$29.6K | 0.87% | 34 |
|
|
2025
Q1 | $4.84M | Sell |
190,944
-1,241
| -0.6% | -$32.5K | 1.05% | 26 |
|
|
2024
Q4 | $5.1M | Buy |
192,185
+2,706
| +1% | +$73.4K | 1.21% | 27 |
|
|
2024
Q3 | $5.48M | Buy |
189,479
+4,067
| +2% | +$119K | 1.3% | 26 |
|
|
2024
Q2 | $5.19M | Buy |
185,412
+2,284
| +1% | +$62.9K | 1.3% | 25 |
|
|
2024
Q1 | $5.08M | Buy |
183,128
+2,415
| +1% | +$67K | 1.26% | 28 |
|
|
2023
Q4 | $5.2M | Buy |
180,713
+647
| +0.4% | +$19.6K | 1.41% | 24 |
|
|
2023
Q3 | $5.97M | Buy |
180,066
+1,575
| +0.9% | +$55.7K | 1.8% | 18 |
|
|
2023
Q2 | $6.55M | Buy |
178,491
+2,772
| +2% | +$108K | 1.95% | 17 |
|
|
2023
Q1 | $7.17M | Buy |
175,719
+9,100
| +5% | +$393K | 2.29% | 14 |
|
|
2022
Q4 | $8.54M | Sell |
166,619
-203
| -0.1% | -$9.73K | 3.22% | 4 |
|
|
2022
Q3 | $7.3M | Buy |
166,822
+11,591
| +7% | +$563K | 2.91% | 5 |
|
|
2022
Q2 | $8.14M | Buy |
155,231
+6,542
| +4% | +$333K | 2.85% | 7 |
|
|
2022
Q1 | $7.7M | Buy |
148,689
+219
| +0.1% | +$11.4K | 2.6% | 10 |
|
|
2021
Q4 | $8.77M | Sell |
148,470
-749
| -0.5% | -$37.1K | 2.63% | 6 |
|
|
2021
Q3 | $6.42M | Sell |
149,219
-1,367
| -0.9% | -$60.6K | 1.99% | 13 |
|
|
2021
Q2 | $5.9M | Buy |
150,586
+1,034
| +0.7% | +$40.2K | 1.76% | 16 |
|
|
2021
Q1 | $5.42M | Buy |
149,552
+5,292
| +4% | +$188K | 1.7% | 17 |
|
|
2020
Q4 | $5.31M | Sell |
144,260
-4,525
| -3% | -$166K | 2.17% | 14 |
|
|
2020
Q3 | $5.18M | Sell |
148,785
-30,446
| -17% | -$1.07M | 2.15% | 15 |
|
|
2020
Q2 | $5.56M | Buy |
179,231
+25,631
| +17% | +$871K | 2.48% | 11 |
|
|
2020
Q1 | $4.76M | Buy |
153,600
+5,876
| +4% | +$200K | 2.28% | 12 |
|
|
2019
Q4 | $5.49M | Buy |
147,724
+12,570
| +9% | +$448K | 2.18% | 14 |
|
|
2019
Q3 | $4.61M | Buy |
135,154
+2,983
| +2% | +$108K | 1.9% | 18 |
|
|
2019
Q2 | $5.43M | Sell |
132,171
-1,286
| -1% | -$51.1K | 2.37% | 12 |
|
|
2019
Q1 | $5.38M | Sell |
133,457
-898
| -0.7% | -$36K | 2.4% | 11 |
|
|
2018
Q4 | $5.56M | Sell |
134,355
-2,551
| -2% | -$106K | 2.93% | 9 |
|
|
2018
Q3 | $5.72M | Sell |
136,906
-379
| -0.3% | -$14.6K | 2.63% | 10 |
|
|
2018
Q2 | $4.73M | Sell |
137,285
-1,338
| -1% | -$45.7K | 2.25% | 14 |
|
|
2018
Q1 | $4.64M | Sell |
138,623
-1,610
| -1% | -$55.3K | 2.38% | 11 |
|
|
2017
Q4 | $4.82M | Sell |
140,233
-1,279
| -0.9% | -$43.6K | 2.47% | 11 |
|
|
2017
Q3 | $4.79M | Buy |
141,512
+334
| +0.2% | +$10.7K | 2.54% | 11 |
|
|
2017
Q2 | $4.5M | Buy |
141,178
+2,168
| +2% | +$68.4K | 2.48% | 14 |
|
|
2017
Q1 | $4.51M | Buy |
139,010
+4,694
| +3% | +$148K | 2.85% | 7 |
|
|
2016
Q4 | $4.14M | Buy |
134,316
+1,742
| +1% | +$53.2K | 2.81% | 11 |
|
|
2016
Q3 | $4.26M | Buy |
132,574
+80,166
| +153% | +$2.68M | 2.84% | 10 |
|
|
2016
Q2 | $1.75M | Sell |
52,408
-52
| -0.1% | -$1.66K | 1.22% | 38 |
|
|
2016
Q1 | $1.48M | Buy |
52,460
+42,022
| +403% | +$1.2M | 1.08% | 41 |
|
|
2015
Q4 | $320K | Buy |
+10,438
| New | +$328K | 0.26% | 54 |
|
Other funds holding PFE
Advisors Management Group's PFE Position: Q2 2026 in Review
Advisors Management Group sold out of Pfizer (PFE) in Q2 2026, closing a stake of 116,330 shares — an estimated $3.27M sold.
Advisors Management Group first reported a position in PFE in Q4 2015 and held it in 42 quarters. The position peaked at $8.77M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Advisors Management Group reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Advisors Management Group sold 116,330 Pfizer shares in Q2 2026, an estimated $3.27M.
- Advisors Management Group first reported a position in Pfizer in Q4 2015 and held it in 42 quarters.
- Advisors Management Group's Pfizer position peaked at $8.77M in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Advisors Management Group's 13F filing for Q2 2026, filed 4 Aug 2026.